The evolution of poly(ADP-ribose) polymerase inhibitors in the treatment of breast cancer.
The evolution of poly(ADP-ribose) polymerase inhibitors in the treatment of breast cancer.
Clin Adv Hematol Oncol. 2018 May;16(5):330-332
Authors: Domchek SM
PMID: 29851928 [PubMed - in process]
Source: Clinical Advances in Hematology and Oncology - Category: Cancer & Oncology Tags: Clin Adv Hematol Oncol Source Type: research